Iodide

Iodide

SCHEMBL720052

COCC[N+]1(C)CCCCCC1.[I-]

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 known ✓ P11229 1/20 0.35
CHRM3 known ✓ P20309 1/20 0.35
KDM4E B2RXH2 2/20 1.00
LMNA P02545 3/20 0.46
APOBEC3A P31941 3/20 0.46
APOBEC3G Q9HC16 3/20 0.46
KMT2A Q03164 2/20 0.46
CDC25A P30304 1/20 0.44
CHRNB2 P17787 4/20 0.42
CHRNA4 P43681 4/20 0.42
CHRNB4 P30926 3/20 0.42
CHRNA3 P32297 3/20 0.42
CHRNA7 P36544 3/20 0.42
CHRNA10 Q9GZZ6 3/20 0.42
CHRNA9 Q9UGM1 3/20 0.42
TP53 P04637 1/20 0.39
HTT P42858 3/20 0.38
CTDSP1 Q9GZU7 2/20 0.38
BBOX1 O75936 2/20 0.38
ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL14877089 1.00 KDM4E (1.00) KDM4ELMNAAPOBEC3AAPOBEC3GKMT2A
SCHEMBL372822 0.98 KDM4E (0.95) KDM4ELMNAAPOBEC3AAPOBEC3GKMT2A
Iodide SCHEMBL14876646 0.98 KDM4E (0.95) KDM4ELMNAAPOBEC3AAPOBEC3GKMT2A
SCHEMBL718386 0.98 KDM4E (0.95) KDM4ELMNAAPOBEC3AAPOBEC3GKMT2A
Bromide SCHEMBL2354539 0.95 KDM4E (0.91) KDM4ELMNAAPOBEC3AAPOBEC3GKMT2A
Water SCHEMBL15375367 0.95 KDM4E (0.91) KDM4ELMNAAPOBEC3AAPOBEC3GKMT2A
SCHEMBL372602 0.95 KDM4E (0.91) KDM4ELMNAAPOBEC3AAPOBEC3GKMT2A
Hydrochloric Acid SCHEMBL17022299 0.93 KDM4E (0.86) KDM4ELMNAAPOBEC3AAPOBEC3GKMT2A
Bromide SCHEMBL717429 0.93 KDM4E (0.86) KDM4ELMNAAPOBEC3AAPOBEC3GKMT2A
SCHEMBL23484985 0.90

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8345407-B2 Low viscosity ionic liquids INVISTA NORTH AMERICA S.A R.L. (US) 2013-01-01 US disclosed
EP-2534134-A1 LOW VISCOSITY IONIC LIQUIDS Invista Technologies S.à.r.l. (CH) 2012-12-19 EP disclosed
US-20120050945-A1 LOW VISCOSITY IONIC LIQUIDS INVISTA NORTH AMERICA S.A R.L. (US) 2012-03-01 US disclosed
WO-2011100232-A1 LOW VISCOSITY IONIC LIQUIDS INVISTA TECHNOLOGIES S.A R.L. (CH) 2011-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120050945-A1 LOW VISCOSITY IONIC LIQUIDS H1-3, H1-0, H1-2 CHRM1 30/4885CHRM3 40/4885KDM4E 1489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.